Package 16571-788-50

{"route": ["ORAL"], "spl_id": "c6ae1c97-1923-4afe-b409-89c41de30e60", "openfda": {"nui": ["N0000008486"], "unii": ["44YRR34555"], "rxcui": ["311288", "311289", "311290", "387003"], "spl_set_id": ["d2f5416c-631d-48cc-a6ce-f998c7217d70"], "pharm_class_pe": ["Decreased Central Nervous System Disorganized Electrical Activity [PE]"], "manufacturer_name": ["Rising Pharma Holdings, Inc."], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "500 TABLET, FILM COATED in 1 BOTTLE (16571-788-50)", "package_ndc": "16571-788-50", "marketing_end_date": "20260331", "marketing_start_date": "20090115"}], "brand_name": "Levetiracetam", "product_id": "16571-788_c6ae1c97-1923-4afe-b409-89c41de30e60", "dosage_form": "TABLET, FILM COATED", "pharm_class": ["Decreased Central Nervous System Disorganized Electrical Activity [PE]"], "product_ndc": "16571-788", "generic_name": "Levetiracetam", "labeler_name": "Rising Pharma Holdings, Inc.", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Levetiracetam", "active_ingredients": [{"name": "LEVETIRACETAM", "strength": "500 mg/1"}], "application_number": "ANDA078993", "marketing_category": "ANDA", "marketing_end_date": "20260331", "marketing_start_date": "20090115"}